Ubiquitin‐mediated control of oncogene and tumor suppressor gene products

Cancer Science - Tập 100 Số 8 - Trang 1374-1381 - 2009
Kyoko Kitagawa1, Yojiro Kotake1, Masatoshi Kitagawa1
1Department of Biochemistry 1, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan

Tóm tắt

Cellular levels of products from both oncogenes and tumor suppressor genes in normal cells need to be critically regulated to avoid malignant transformation. These products are often controlled by the ubiquitin proteasome pathway, the specific degradation mechanism in the cell. E3 ubiquitin ligases polyubiquitylate their specific substrates by collaborating with E1 and E2, and then the modified substrates are degraded in the proteasome. Mdm2 targets p53 and retinoblastoma protein, two major tumor suppressor gene products, for ubiquitin‐dependent degradation. SCFSkp2 targets other tumor suppressor gene products and CDK inhibitors such as p130, Tob1, p27Kip1, p57Kip2, and p21Cip1. Therefore, both E3 ligases act like oncogene products. In contrast, degradation of several oncogene products, such as Cyclin E, Notch, c‐Myc, c‐Jun, and c‐Myb, are mediated by SCFFbw7. Fbw7 is often deleted or mutated in human cancers and acts like a tumor suppressor. As well as growth factor receptors and signal transduction regulators, DNA repair‐related proteins are also regulated via the ubiquitin–proteasome pathway mediated by their specific E3 ligases. The stabilization of oncogene products and enhanced degradation of tumor suppressor gene products or DNA repair proteins might be associated with carcinogenesis and malignant progression, due to defects or the abnormal expression of their E3 ligases. (Cancer Sci 2009)

Từ khóa


Tài liệu tham khảo

10.1038/sj.cdd.4401702

10.1146/annurev.biochem.67.1.425

10.1038/nrc1881

10.1038/nrm1471

10.1073/pnas.96.7.3859

10.1093/emboj/18.9.2401

10.1126/science.1065203

10.1038/sj.emboj.7600217

10.1073/pnas.0402770101

10.1016/j.ccr.2005.06.005

10.1186/gb-2000-1-5-reviews3002

10.1038/12013

10.1093/emboj/19.9.2069

10.1038/35060126

10.1073/pnas.1831009100

10.1101/gad.1011202

10.1158/0008-5472.CAN-06-1603

10.1016/S1097-2765(03)00193-X

Imaki H, 2003, Cell cycle‐dependent regulation of the Skp2 promoter by GA‐binding protein, Cancer Res, 63, 4607

10.1016/S0002-9440(10)64172-7

10.1074/jbc.M804340200

KitagawaK HiramatsuY UchidaCet al.Fbw7 promotes ubiquitin‐dependent degradation of c‐Myb: involvement of GSK3‐mediated phosphorylation of Thr‐572 in mouse c‐Myb.Oncogenein press.

10.1128/MCB.21.21.7403-7415.2001

10.1126/science.1162981

10.1084/jem.20070872

10.1084/jem.20062299

10.4161/cbt.5.2.2479

10.1074/jbc.C000881200

10.1016/j.ccr.2008.06.001

10.1111/j.1349-7006.2008.00925.x

10.1016/j.molcel.2006.01.020

10.1016/0092-8674(93)90384-3

10.1016/j.cell.2005.03.037

10.1016/S0014-5793(97)01480-4

10.1016/S0092-8674(03)00193-4

10.1038/nature02514

10.1093/jnci/djh292

10.1038/sj.emboj.7600444

10.4161/cc.5.16.3260

10.1038/cdd.2008.134

10.1016/0092-8674(95)90385-2

10.1002/j.1460-2075.1996.tb01097.x

10.1038/sj.emboj.7600486

10.1038/358080a0

10.1016/j.bbrc.2005.11.148

10.1016/S0092-8674(00)81400-2

10.1093/emboj/18.1.22

10.1016/0092-8674(95)90214-7

10.1016/j.biocel.2007.03.022

10.1016/j.febslet.2006.02.029

10.1002/(SICI)1521-1878(199812)20:12<1020::AID-BIES8>3.0.CO;2-D

10.1038/ncb1194

10.1158/0008-5472.CAN-07-2033

10.1038/nrc2396

10.1016/S0006-291X(03)00469-8

10.1111/j.1349-7006.2009.01122.x

10.1074/jbc.M301774200

10.1016/j.molcel.2007.06.013

10.1101/gad.1676108

10.1101/gad.1213904

10.1016/j.cell.2006.11.039

10.1158/0008-5472.CAN-07-6231

10.1016/j.molcel.2006.09.007

Kimura Y, 2007, MM‐1 facilitates degradation of c‐Myc by recruiting proteasome and a novel ubiquitin E3 ligase, Int J Oncol, 31, 829

10.1038/sj.onc.1210059

10.1159/000066755

10.1593/neo.06442

10.1038/20459

10.1016/j.molcel.2006.08.005

10.1016/S1097-2765(01)00183-6

10.1016/S0092-8674(02)00615-3

10.1016/j.ceb.2007.02.014

10.1101/gad.1483206

10.1038/nature05175

10.1038/ncb1490

10.1016/j.molcel.2006.08.010

10.1016/j.molcel.2006.06.029

10.1016/S0092-8674(03)00316-7

10.1016/j.cell.2005.02.035

10.1073/pnas.0511160103

10.1016/j.molcel.2006.03.035

10.1158/0008-5472.CAN-08-2739

Thông tin
Thông tin xuất bản

Cancer Science

Tập 100 Số 8

1374-1381

Thông tin tác giả